The CNIC-polypill (acetylsalicylic acid, atorvastatin, and ramipril), an effective and cost-saving secondary prevention strategy compared with other therapeutic options in patients with ischaemic heart disease
- Dalmau, R.
- Cordero, A.
- Masana, L.
- Ruiz, E.
- Sicras-Mainar, A.
- González-Juanatey, J.R.
Revista:
European Heart Journal Open
ISSN: 2752-4191
Ano de publicación: 2024
Volume: 4
Número: 2
Tipo: Artigo
